Olink

Olink®
Part of Thermo Fisher Scientific

Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search.  Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filter

Filters

Publication
Disease Area
Application Area
Sample Type
Products

Scientific Reports, 2022

Investigation of 91 proteins implicated in neurobiological processes identifies multiple candidate plasma biomarkers of stroke outcome

Lagging C., Klasson S., Pedersen A. et al.

Journal of Cellular and Molecular Medicine, 2022

Glucose and lipopolysaccharide differentially regulate fibroblast growth factor 21 in healthy male human volunteers – A prospective cross‐over trial

Pohlhammer J., Heinzl M., Klammer C. et al.

Scientific Reports, 2022

Protein biomarkers of cardiac remodeling and inflammation associated with HFpEF and incident events

Regan J., Truby L., Tahir U. et al.

iScience, 2022

A protein signature associated with active tuberculosis identified by plasma profiling and network-based analysis

Mousavian Z., Folkesson E., Fröberg G. et al.

American Journal of Respiratory and Critical Care Medicine, 2022

Plasticity of Individual Lung Function States from Childhood to Adulthood

Wang G., Hallberg J., Faner R. et al.

Scandinavian Journal of Work, Environment & Health, 2022

Short and long-term associations between serum proteins linked to cardiovascular disease and particle exposure among constructions workers

Gliga A., Grahn K., Gustavsson P. et al.

Antiviral Research, 2022

Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier

Faist A., Schloer S., Mecate-Zambrano A. et al.

Emerging Microbes & Infections, 2022

Distinct inflammation-related proteins associated with T cell immune recovery during chronic HIV-1 infection

Wan L., Huang H., Zhen C. et al.

Alzheimer's Research & Therapy, 2022

Multi-platform proteomic analysis of Alzheimer’s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome

Dammer E., Ping L., Duong D. et al.

Scientific Reports, 2022

Plasma proteomic characterization of the development of acute kidney injury in early sepsis patients

Star B., Boahen C., van der Slikke E. et al.

Archives of Microbiology & Immunology, 2022

Circulating Cell-Free DNA and Systemic Inflammatory Response after Self-Expandable Metal Stent for Malignant Bowel Obstruction

Broholm M, Bojesen R, Gögenur M et al.

Diagnostics, 2022

Proteomic Analysis of Pleural Effusions from COVID-19 Deceased Patients: Enhanced Inflammatory Markers

Razaghi A., Szakos A., Alouda M. et al.

Clinical Proteomics, 2022

Determination of temporal reproducibility and variability of cancer biomarkers in serum and EDTA plasma samples using a proximity extension assay

Christensen T., Maag E., Madsen K. et al.

Nature Aging, 2022

CSF proteome profiling across the Alzheimer’s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels

del Campo M., Peeters C., Johnson E. et al.

European Heart Journal Open, 2022

NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patients

Rossignol P., Duarte K., Bresso E. et al.

Human Molecular Genetics, 2022

Identifying causal serum protein–cardiometabolic trait relationships using whole genome sequencing

Png G., Gerlini R., Hatzikotoulas K. et al.

BMJ Open Diabetes Research & Care, 2022

Pregnancy induces pancreatic insulin secretion in women with long-standing type 1 diabetes

Espes D., Magnusson L., Caballero-Corbalan J. et al.

Obesity, 2022

The inflammatory proteome, obesity, and medical weight loss and regain in humans

Perry A., Tanriverdi K., Risitano A. et al.

Clinical and Translational Science, 2022

ST2 and CSF‐1 as potential druggable targets of inflammatory bowel diseases: Results from two‐sample Mendelian randomization study

Mi J., Wu X., Bai X. et al.

Journal of Clinical Immunology, 2022

Combination of WFDC2, CHI3L1, and KRT19 in Plasma Defines a Clinically Useful Molecular Phenotype Associated with Prognosis in Critically Ill COVID-19 Patients

Ebihara T., Matsubara T., Togami Y. et al.

4555 publications